Sun Pharma Advanced Research Company Ltd has announced that a meeting of the Board of Directors of the Company will be held on March 05, 2016, inter alia, to fix the Issue Price, Issue Size, Rights Entitlement Ratio, Fractional Entitlement and Record Date.
Sun Pharma Advanced Research Company Ltd has announced that a meeting of the Board of Directors of the Company will be held on March 05, 2016, inter alia, to fix the Issue Price, Issue Size, Rights Entitlement Ratio, Fractional Entitlement and Record Date / Book Closure Dates for determining eligibility of the shareholders to whom the equity shares are to be issued under the proposed Rights Issue of the Company.
Further, in view of the above the trading window for of dealing with equity shares of the Company by the Designated Persons has been closed with immediate effect and shall continue to remain closed until March 09, 2016.
Sun Pharma Advanced Research Company Ltd ended at Rs. 280.15, up by Rs. 16.55 or 6.28% from its previous closing of Rs. 263.6 on the BSE.
The scrip opened at Rs. 268 and touched a high and low of Rs. 283.7 and Rs. 266.75 respectively. A total of 488949(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 6631.15 crore.
The BSE group 'A' stock of face value Rs. 1 touched a 52 week high of Rs. 598 on 10-Mar-2015 and a 52 week low of Rs. 245.1 on 25-Feb-2016. Last one week high and low of the scrip stood at Rs. 283.7 and Rs. 245.1 respectively.
The promoters holding in the company stood at 67.4 % while Institutions and Non-Institutions held 7.99 % and 24.61 % respectively.
The stock traded above its 200 DMA.
No comments:
Post a Comment